| |
|
|
|
Evofem Biosciences Inc.  
|
|
4.09 0.36 (0.1%) |
04-18 16:00 |
|
Open: |
3.79 |
Pre close: |
3.73 |
Target:
|
5.37 
|
|
High: |
4.145 |
Low: |
3.74 |
Resistance:
|
4.60
5.37
|
|
Volume: |
32,933 |
Market Cap: |
142M |
Support:
|
3.73
3.19
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.02
|
MACD |
MACD(12,26):
|
0.12 |
|
MA(20): |
3.67 |
Signal(12,26,9): |
0.07 |
|
MA(100): |
3.64 |
Stochastic Oscillator |
%K(14,3):
|
54.37  |
|
MA(250): |
3.70 |
%D(3): |
56.97 |
|
Average Volume(K) |
3-Month: |
2967
|
52-Week |
High:
|
8.35 |
|
10-Days: |
7851 |
Low: |
1.79 |
|
RSI |
RSI(14):
|
62.71 |
Change(%): |
-34.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.400 |
Return on Equity (ttm) |
83.7 |
Shares Out. (M) |
28.16 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-3227.9 |
Shares Float (M) |
26.80 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
-0.10 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
138.00 |
|
Forward EPS |
-1.520 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
16.480 |
EBITDA (p.s.) |
0.000 |
P/E |
-1.70 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.25 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-56.50 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-110.40 |
P/CF |
-2.04 |
|
|
|
|
|
|
